Onderneming Neurokine Pharmaceuticals Inc Other OTC
Aandelen
CAC611561100
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
01/05 | BetterLife Pharma gaat verder met IND-ondersteunende studies voor BETR-001 | MT |
01/05 | BetterLife Pharma Inc. vordert BETR-001 IND-onderzoeken | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26-12-10 |
Chief Operating Officer | 67 | - | |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
David Melles
IRC | Investor Relations Contact | - | 29-09-21 |
Anthony Calandra
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
Ralph Pullen
BRD | Director/Board Member | 79 | 05-05-20 |
Steven Sangha
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 113 825 305 | 88 051 525 ( 77,36 %) | 0 | 77,36 % |
Bedrijfsgegevens
BetterLife Pharma, Inc.
1275 West 6th Avenue Suite 300
V6H 1A6, Vancouver
+604 221 0595
http://www.abetterlifepharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers BETRF
- Koers
- Onderneming Neurokine Pharmaceuticals Inc